NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 24 04:00PM ET
3.68
Dollar change
+0.35
Percentage change
10.51
%
Index- P/E- EPS (ttm)-0.57 Insider Own24.97% Shs Outstand298.36M Perf Week16.46%
Market Cap1.10B Forward P/E- EPS next Y-0.55 Insider Trans0.00% Shs Float223.95M Perf Month84.00%
Enterprise Value536.00M PEG- EPS next Q-0.14 Inst Own41.08% Short Float10.20% Perf Quarter42.08%
Income-167.87M P/S47.51 EPS this Y-10.77% Inst Trans12.81% Short Ratio4.57 Perf Half Y36.80%
Sales23.12M P/B1.07 EPS next Y10.02% ROA-11.96% Short Interest22.84M Perf YTD25.60%
Book/sh3.43 P/C1.74 EPS next 5Y0.83% ROE-15.59% 52W High3.68 0.00% Perf Year25.17%
Cash/sh2.11 P/FCF- EPS past 3/5Y- -107.74% ROIC-15.45% 52W Low1.89 94.65% Perf 3Y-60.26%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-57.49% 19.95% Gross Margin-318.94% Volatility7.15% 5.48% Perf 5Y-
Dividend TTM- EV/Sales23.18 EPS Y/Y TTM-12.26% Oper. Margin-1395.34% ATR (14)0.24 Perf 10Y-
Dividend Ex-Date- Quick Ratio10.15 Sales Y/Y TTM-35.41% Profit Margin-726.23% RSI (14)78.19 Recom1.25
Dividend Gr. 3/5Y- - Current Ratio10.15 EPS Q/Q-10.45% SMA2033.72% Beta0.52 Target Price8.33
Payout- Debt/Eq0.07 Sales Q/Q-57.45% SMA5049.54% Rel Volume1.62 Prev Close3.33
Employees596 LT Debt/Eq0.06 EarningsMay 08 AMC SMA20037.14% Avg Volume5.00M Price3.68
IPODec 11, 2020 Option/ShortYes / Yes EPS/Sales Surpr.-10.21% -41.49% Trades Volume8,123,027 Change10.51%
Date Action Analyst Rating Change Price Target Change
Aug-20-24Downgrade The Benchmark Company Buy → Hold
Feb-22-24Upgrade The Benchmark Company Hold → Buy $9
Dec-05-23Initiated KeyBanc Capital Markets Overweight $6
Nov-06-23Downgrade The Benchmark Company Buy → Hold
Oct-13-23Resumed Piper Sandler Overweight $20
Feb-28-23Initiated Cowen Outperform
Dec-15-22Initiated Goldman Buy $30
Nov-16-22Initiated Truist Buy $29
Dec-21-21Initiated The Benchmark Company Buy $27
Nov-19-21Initiated Piper Sandler Overweight $33
Today 04:09AM
Jun-09-25 09:13AM
Jun-03-25 12:00PM
Jun-02-25 06:45PM
May-30-25 01:00PM
11:21AM Loading…
May-21-25 11:21AM
May-14-25 05:00PM
May-12-25 03:30PM
May-09-25 07:30PM
11:22AM
03:50AM
May-08-25 06:05PM
04:05PM
May-07-25 12:39PM
10:45AM
03:00PM Loading…
Apr-29-25 03:00PM
Apr-23-25 10:14AM
Apr-16-25 11:59PM
Apr-08-25 04:05PM
Apr-03-25 04:05PM
Mar-25-25 04:30PM
Feb-28-25 02:18PM
02:43AM
Feb-27-25 10:15PM
06:15PM
04:05PM
Feb-26-25 07:55AM
Feb-11-25 04:05PM
Jan-21-25 04:05PM
Jan-17-25 07:53AM
10:47AM Loading…
Jan-15-25 10:47AM
Jan-14-25 09:25AM
Jan-13-25 09:00AM
Jan-07-25 09:11AM
Nov-21-24 04:05PM
Nov-07-24 10:05AM
Nov-05-24 11:17AM
02:11AM
Nov-04-24 11:00PM
05:55PM
04:05PM
Nov-01-24 09:06AM
Oct-22-24 04:05PM
Oct-16-24 08:58AM
Oct-04-24 09:00AM
Sep-26-24 04:05PM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
04:05PM
05:13AM
Aug-07-24 12:45AM
Aug-06-24 06:15PM
04:05PM
Aug-01-24 06:32AM
Jul-31-24 09:00AM
Jul-21-24 05:37AM
Jul-09-24 12:00PM
Jun-25-24 04:05PM
Jun-13-24 05:40AM
May-28-24 04:05PM
May-13-24 06:00AM
May-08-24 11:03AM
07:01AM
04:30AM
May-07-24 08:57PM
06:05PM
06:01PM
04:05PM
May-01-24 09:00AM
Apr-30-24 10:01AM
Apr-08-24 12:05PM
Apr-03-24 04:05PM
Mar-27-24 04:30PM
Mar-26-24 05:25PM
Mar-19-24 04:05PM
Mar-11-24 09:00AM
Mar-05-24 04:30PM
Feb-26-24 06:55AM
Feb-23-24 04:30PM
Feb-22-24 08:15PM
Feb-21-24 09:22AM
07:09AM
Feb-20-24 11:00PM
07:00PM
04:57PM
04:05PM
Jan-30-24 01:02PM
Jan-23-24 04:05PM
Jan-15-24 09:30AM
Jan-03-24 09:40AM
Dec-20-23 04:05PM
Dec-16-23 01:00PM
Dec-11-23 03:30PM
Nov-16-23 04:05PM
Nov-03-23 12:05PM
10:51AM
08:42AM
05:55AM
05:30AM
Nov-02-23 05:56PM
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.